Solazyme Inc  

(Public, NASDAQ:SZYM)   Watch this stock  
Find more results for SZYM
2.34
-0.60 (-20.41%)
Jul 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.25 - 2.58
52 week 2.00 - 10.20
Open 2.52
Vol / Avg. 1.68M/733,086.00
Mkt cap 187.36M
P/E     -
Div/yield     -
EPS -1.97
Shares 80.06M
Beta 1.55
Inst. own 58%
Jul 30, 2015
Q2 2015 Solazyme Inc Earnings Call - Webcast
Jul 30, 2015
Q2 2015 Solazyme Inc Earnings Release
May 28, 2015
Solazyme Inc at Cowen Technology, Media & Telecom Conference
May 14, 2015
Solazyme Inc Annual Shareholders Meeting
May 6, 2015
Q1 2015 Solazyme Inc Earnings Call
May 6, 2015
Q1 2015 Solazyme Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -316.62% -268.49%
Operating margin -224.17% -224.67%
EBITD margin - -208.42%
Return on average assets -57.64% -56.76%
Return on average equity -425.25% -143.92%
Employees 266 -
CDP Score - -

Address

225 Gateway Blvd
SOUTH SAN FRANCISCO, CA 94080-7019
United States - Map
+1-650-7804777 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Solazyme, Inc. creates renewable oils and bioproducts. The Company's technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company's commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.

Officers and directors

Jerry L. Fiddler Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Jonathan S. Wolfson JD Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Tyler W. Painter Chief Financial Officer, Chief Operating Officer
Age: 43
Bio & Compensation  - Reuters
Peter J. Licari Ph.D. Chief Technology Officer
Age: 51
Bio & Compensation  - Reuters
Paul T. Quinlan General Counsel, Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Michael V. Arbige Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Ian T. Clark Independent Director
Age: 54
Bio & Compensation  - Reuters
James R. Craigie Independent Director
Age: 61
Bio & Compensation  - Reuters
Gary M. Pfeiffer Independent Director
Age: 65
Bio & Compensation  - Reuters